Quantitation of immunoglobulin free light chains in cerebrospinal fluid: The experience of two Italian laboratories;La determinazione delle catene leggere libere nel liquido cefalorachidiano: L'esperienza di due laboratori italiani

Biochimica Clinica

Volumn 37, Issue 5, 2013, Pages 389-394

  Bernardi, Gaetano ^a   Cataldo, Ivana ^b  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b Ospedale Clinicizzato SS Annunziata   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; OLIGOCLONAL BAND; POLYCLONAL ANTIBODY;

ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL LABORATORY; CONTROLLED STUDY; GOLD STANDARD; HUMAN; IMMUNOASSAY; IMMUNODETECTION; IMMUNOGLOBULIN BLOOD LEVEL; ISOELECTRIC FOCUSING; MONOCLONAL ANTIBODY BASED ASSAY; MULTIPLE SCLEROSIS; NEPHELOMETRY; NEUROLOGIC DISEASE; NON INFLAMMATORY NEUROLOGICAL DISEASE; POLYCLONAL ANTIBODY BASED ASSAY; SENSITIVITY AND SPECIFICITY;

EID: 84889243562     PISSN: 03930564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bracco F, Gallo P, Menna R, et al. Free light chains in the CSF in multiple sclerosis. J Neurol 1987;234:303-7.
2. DeCarli C, Menegus MA, Rudick RA. Free light chains in multiple sclerosis and infections of the CNS. Neurology 1987;37:1334-8.
3. Bradwell AR, Carr-Smith HD, Mead GP, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001;47:673-80.
4. Fischer C, Arneth B, Koehler J, et al. Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis.Clin Chem 2004;50:1809-13.
5. Desplat-Jégo S, Feuillet L, Pelletier J et al. Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry.J Clin Immunol 2005;25:338-45.
6. Presslauer S, Milosavljevic D, Brücke T, et al. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis. J Neurol 2008;255:1508- 14.
7. Arneth B, Birklein F. High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid. Acta Neurol Scand 2009;119:39-44.
8. Villar LM, Espiño M, Costa-Frossard L, et al. High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis. Clin Chim Acta 2012;413:1813-6.
9. Hildebrandt B, Müller C, Pezzutto A, et al. Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis - a pilot study. BMC Cancer 2007;7:185.
10. Schroers R, Baraniskin A, Heute C, et al. Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas. Eur J Haematol 2010;85:520-8.
11. MacDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7.
12. Bernardi G, Ciusani E, Croci D, et al. Le proteine liquorali. In: Trattato italiano di medicina di laboratorio. Spandrio L, ed. Vol. II. Padova: Piccin Nuova Libraria, 2006:15-30.
13. Lunding J, Midgard R, Vedeler CA. Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focusing, agorose gel electrophoresis and IgG index. Acta Neurol Scand 2000;102:322-5.
14. Reiber H, Otto M, Trendelenburg C, et al. Reporting cerebrospinal fluid data: knowledge base and interpration software. Clin Chem Lab Med 2001;39:324-32.
15. Reiber H. Free light chains in CSF - pushing a method with biased interpretations. Acta Neurol Scand 2009:120:445-6.
16. Arneth B. In reply to comment on "High sensitivity of free lambda and free kappa light chains for the detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid". Acta Neurol Scand 2009;120:451-2.
17. Fagnart OC, Sindic CJ, Laterre C. Free kappa and lambda light chain levels in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. J. Neuroimmunol 1988;19:119-32.